Pharmaceuticals & Therapeutics

Forget perfect guidance. The future of stroke rehab may lie in making mistakes. Israel's Bioxtreme launches Dextreme 2.0, using AI to amplify errors and accelerate recovery.

A Dutch medtech firm is advancing a pivotal study for its VCFix® system, a device that aims to reconstruct vertebrae rather than just fill them.

A new partnership between Medventions and Mitacs aims to fix Canada's innovation gap by embedding engineers directly into clinics. Here's how it works.

A new partnership aims to replace needles with pills for a powerful class of drugs, using advanced AI to solve a multi-billion dollar challenge in medicine.

HPQ Silicon's new LOI aims to localize critical drone propulsion tech, but can a non-binding pact with French innovators truly break Asia's supply chain grip?

As federal support for science wanes, the National Cancer Center adds top minds from Stanford and Harvard to identify and fund the next wave of cancer cures.

Gelteq aims to replace needles with its ingestible gel, targeting diabetes and more. But can it balance this lofty goal with near-term revenue and tight finances?

An Israeli biotech just published a patent for a 'mucoadhesive' gel that makes drugs stick inside the nose. It's a key step in a multi-billion dollar race.

A key update to a revolutionary cancer therapy reduces post-treatment restrictions, signaling a new era of patient-centric care and system efficiency in Canada.

With a history of beating expectations and a flurry of strategic moves, Quest Diagnostics' July 23rd earnings report is a key vital sign for the entire diagnostics sector.

Dole's new luxury pineapple is more than a sweet treat; its profits are building a community center in Honduras. Is this a new blueprint for corporate accountability?

Rare complete responses in deadly pancreatic cancer hint at a powerful new synergy, but can Elicio Therapeutics secure the funding to prove its theory?

Insilico Medicine's AI-designed drug, ISM8969, enters human trials, targeting chronic neuroinflammation by crossing the elusive blood-brain barrier.

With a key regulatory win in the UAE, WAT Medical is set to introduce its drug-free neuromodulation devices to a booming Middle Eastern healthcare market.

A new survey reveals Tennessee seniors delay hearing care for years due to cost fears, risking cognitive decline and falls. But are the solutions already here?

As lawsuits plague synthetic weed killers, Akron-based Lanaturo unveils Salacia, the first selective organic herbicide guided by AI, shaking up the lawn care industry.

Glass House Brands follows a new playbook, splitting its business to chase a NYSE listing. Is this the key that unlocks institutional capital for the entire sector?

Three of Europe's largest steelmakers warn the EU's climate policy could gut manufacturing. Is this a genuine crisis or a last-ditch bid to delay the inevitable?

As the world scrambles for lithium, Canadian developer Lithium Ionic heads to a key conference, showcasing its advanced Brazilian project and its role in a new supply chain.

New data on ersodetug reveals a calculated strategy to conquer hyperinsulinism, balancing patient hope with the harsh realities of the biotech market.